
Lowering blood pressure to a healthy range may result in a reduction in dementia, memory loss, and other forms of cognitive decline. In a new study, researchers lowered patients systolic blood pressure to 120 mmHg and found that they were 19% less likely to develop mild cognitive development that commonly precedes Alzheimer’s, and 15% less likely to later display dementia and cognitive decline.
These results were generated from large blood pressure trial called the Systolic Blood Pressure Intervention Trial (SPRINT), a dataset that has already found blood pressure management to be associated with cardiovascular and kidney diseases. These earlier results from the SPRINT study led to the American Heart Association and American College of Cardiology lowering their standard for high blood pressure from 140 mmHg to 130 mmHg.
In this study, the researchers used 9,000 patients with cardiovascular issues and reduced their blood pressure to a certain level, some below 120 mmHg, others only below 140. This reduction was achieved in a number of ways, including exercise and diet changes, as well as use of medication.